Niagen Bioscience, Inc. reports

Company Names, identifiers, and filing context for this profile. 1 identity field
Company location
Los Angeles, CA
SEC filing record 1 source field available
Fiscal year end
31 December
Niagen Bioscience, Inc. has filed 977 SEC EDGAR filings since 18 Jan 2007

SEC filing history

Showing 51-75 of 924 matching filings.

Per page
25
Current page
3
ARS File 001-37752

ARS

Filing date
29 Apr 2025
Reporting date
31 Dec 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
DEFA14A File 001-37752

DEFA14A

Filing date
29 Apr 2025
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
DEF 14A File 001-37752

DEF 14A

Filing date
29 Apr 2025
Reporting date
31 Dec 2024
Next action
Verify source filing
4

FORM 4

Filing date
09 Apr 2025
Reporting date
09 Apr 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
10 Mar 2025
Reporting date
07 Mar 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
27 Feb 2025
Reporting date
25 Feb 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
14 Feb 2025
Reporting date
12 Feb 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
14 Feb 2025
Reporting date
12 Feb 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
14 Feb 2025
Reporting date
12 Feb 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
13 Dec 2024
Reporting date
13 Dec 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
144 File 001-37752

144 filing

Filing date
13 Dec 2024
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
25 Nov 2024
Reporting date
22 Nov 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
424B3 File 333-272828

PROSPECTUS SUPPLEMENT

Filing date
21 Nov 2024
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
3

FORM 3

Filing date
08 Nov 2024
Reporting date
07 Nov 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
23 Oct 2024
Reporting date
21 Oct 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .